Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) appears in 268 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 525,584 | 6.13% | $0.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,486,000 | 14.18% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 564,604 | 1,449.97% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 107,846 | 1.51% | $0.00 |
| Rubric Capital Management LP | 31 Dec, 2025 | 0 | -2,477,880 | -23.05% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -247,782 | -42.77% | $0.00 |
| JENNISON ASSOCIATES LLC | 31 Dec, 2025 | 0 | -5,496,113 | -44.85% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | 257,415 | 4.86% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 846,986 | 18.25% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 294,994 | 10.01% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 63,845 | 1.49% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 11,804 | 0.86% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 146,842 | 5.63% | $0.00 |
| Pivotal bioVenture Partners Investment Advisor LLC | 31 Dec, 2025 | 0 | -753,884 | -35.55% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 564,374 | 26.64% | $0.00 |
| Perpetual Ltd | 31 Dec, 2025 | 0 | -1,113,976 | -55.02% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 1,465,441 | 133.59% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -153,152 | -18.80% | $0.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 0 | -410,935 | -17.78% | $0.00 |